Listen
DIACOMIT
-
Opinions on drugs -
Posted on
Aug 01 2008
- Updated on
Jan 12 2010
Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals
-
Clinical Benefit
| Substantial |
The actual benefit of DIACOMIT is substantial. |
Clinical Added Value
| moderate |
DIACOMIT provides a moderate (level III) improvement in actual benefit in the management of patients with severe myoclonic epilepsy in infancy when the sodium valproate-clobazam combination does not provide adequate control. |
Contact Us
Évaluation des médicaments
